Search for drugs:
Typing the drug name to query
BACILLUS ANTHRACIS
DIR Classification
Classification:Less-DIR concern
Severity Score:1
Description in Drug Labeling: View Full Labeling: SPL in DailyMed | PDF
- ADVERSE REACTIONS
- Postmarketing Experience
- The following adverse events have been reported spontaneously. Since these events are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. The reports included below are listed due to one or more of the following factors: (1) seriousness of the event, (2) number of reports, or (3) strength of causal relationship to the drug.
- Blood and lymphatic system disorders
- Lymphadenopathy
- Gastrointestinal Disorders
- Nausea
- Immune system disorders
- Allergic reactions (including anaphylaxis, angioedema, rash, urticaria, pruritus, erythema multiforme, anaphylactoid reaction, and Stevens Johnson syndrome)
- Nervous system disorders
- Paresthesia syncope, dizziness, tremor, ulnar nerve neuropathy
- Musculoskeletal, connective tissue, and bone disorders
- Arthralgia, arthropathy, myalgia, rhabdomyolysis, alopecia
- General disorders and administration site conditions
- Malaise, pain, cellulitis, flu-like symptoms
- Psychiatric disorders
- Insomnia
- Skin and Subcutaneous disorders
- Pruritis, rash, urticaria
- Vascular disorders
- Flushing
- Infrequent reports were also received of multisystem disorders defined as chronic symptoms involving at least two of the following three categories: fatigue, mood-cognition, and musculoskeletal system.
Postmarketing Surveillance
Contingency Table:
Current Drug
Other Drugs
Rhabdomyolysis
0
42912
Other ADRs
0
14117279
Odds Ratio = N/A
Drug Property Information
ATC Code(s):
N/A
Active Ingredient:bacillus anthracis strain v770-np1-r antigens
Active Ingredient UNII:873OI62848
Drugbank ID:-
PubChem Compound:N/A
CAS Number:-
Dosage Form(s):injection, suspension
Route(s) Of Administrator:intramuscular; subcutaneous
Daily Dose:
Chemical Structure: 
SMILE Code:
-
-
Reference
COHORT STUDY:
N/AOTHER REFERENCE(S):
N/ADisclaimer:
The content of this database of rhabdomyolysis is intended for educational and scientific research purposes only. It is not intended as a substitute for professional medical advice, diagnosis or treatment.
The views presented in this website do not necessarily reflect current or future opinion or policy of the US Food and Drug Administration. Any mention of commercial products is for clarification and not intended as endorsement.